NEW YORK, March 23, 2018 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against A10 Networks, Inc. (“A10” or the “Company”) (NYSE:ATEN) and certain of its officers, on behalf of shareholders who purchased A10 securities during the period between February 9, 2016 and January 30, 2018, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/aten.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
The complaint alleges that throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (1) A10 Networks had issues with its internal controls that required an Audit Committee investigation; (2) A10 Networks’ revenues since the fourth quarter of 2015 were false due to improper revenue recognition which prompted an investigation by the Company’s Audit Committee; and (3) as a result, Defendants’ public statements were materially false and misleading at all relevant times.
On January 16, 2018, A10 Networks revealed that it expected its fourth quarter 2017 revenue to be between $55.5 million and $56 million, lower than its previous guidance of $64 million to $67 million. Following this news, A10 stock dropped $0.99 per share or over 13% to close at $6.32 per share on January 17, 2018. Then, on January 30, 2018, A10 revealed that its Audit Committee was investigating its revenue recognition practices from the fourth quarter of 2015 through the fourth quarter of 2017. Following this news, A10 stock dropped $0.86 per share or over 12% to close at $6.13 per share on January 31, 2018.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/aten or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in A10 you have until May 21, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]


Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal 



